在安全的癌症治疗中,光皮里米丁核酸的差异性功能
Tim Holzinger1,2, Julia Frei1,2, Natalia Teresa Jarzebska1,3
1Department of Dermatology, University Hospital Zürich (USZ), University of Zürich (UZH).
Anti-cancer drugs
|July 16, 2024
概括
修改后的胺类同类物,5-化素和2'-脱氧-5-化素,显示出作为新型癌症治疗的希望. 当它们被纳入RNA寡核酸中时,它们对癌细胞产生强烈的细胞毒性作用,并可能减少副作用.
科学领域:
- 生物化学 生物化学
- 分子生物学分子生物学
- 癌症研究 癌症研究
背景情况:
- 像5-甲这样的皮里米丁类型是标准化疗,但由于缺乏细胞特异性,会引起严重的副作用.
- 需要更有效,更少毒性的癌症治疗策略.
- 新型药物输送系统对于提高治疗疗效和降低毒性至关重要.
研究的目的:
- 研究5-光细胞素及其衍生物作为新型化疗剂的潜力.
- 为了评估被纳入核糖核酸和RNA寡核酸中的5-光细胞素的细胞毒性作用.
- 评估2 - 脱氧-5 - 化丁的体内治疗潜力和安全性.
主要方法:
- 使用癌细胞系的体外研究.
- 在核糖核酸和RNA寡核酸中纳入5-光细胞素.
- 细胞毒性影响的评估和通过尿素和胆素的救援.
- 在人类初级细胞中,5-化丁和2 - 脱氧-5-化丁之间的毒性比较.
主要成果:
- 当被纳入RNA寡核酸中时,5-细胞氨酸对癌细胞表现出细胞毒性作用,其作用由尿素和胺素挽救.
- 2 -deoxy-5-fluorocytidine在体外抑制了瘤细胞的生长.
- 与5-fluorocytidine相比,2-deoxy-5-fluorocytidine对人类初级细胞的毒性较低.
- 这些发现表明,2-deoxy-5-fluorocytidine可能会减少体内副作用.
结论:
- 5-化素和2 - 脱氧-5 - 化素显示出作为新型化疗剂的前景.
- 含有5-光细胞因子的RNA寡核酸体代表了一类潜在的新型化疗药物.
- 使用癌症特异性颗粒的这些药物的向输送可能会导致更安全,更有效的癌症治疗方法.
相关概念视频
Targeted Cancer Therapies
7.5K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.5K
Treatment Resistant Cancers
3.3K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.3K
Combination Therapies and Personalized Medicine
4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K
Cancer Therapies
7.6K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.6K
DNA Base Pairing
27.2K
Erwin Chargaff’s rules on DNA equivalence paved the way for the discovery of base pairing in DNA. Chargaff’s rules state that in a double-stranded DNA molecule,
27.2K
Adaptive Mechanisms in Cancer Cells
5.7K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.7K


